Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle

TOLLIP (Toll-interacting protein) is an intracellular adaptor protein with diverse actions throughout the body. In a context- and cell type-specific manner, TOLLIP can function as an inhibitor of inflammation and endoplasmic-reticulum stress, an activator of autophagy, or a critical regulator of int...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory cell and molecular biology 2021-05, Vol.64 (5), p.536-546
Hauptverfasser: Li, Xiaoyun, Goobie, Gillian C, Gregory, Alyssa D, Kass, Daniel J, Zhang, Yingze
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 546
container_issue 5
container_start_page 536
container_title American journal of respiratory cell and molecular biology
container_volume 64
creator Li, Xiaoyun
Goobie, Gillian C
Gregory, Alyssa D
Kass, Daniel J
Zhang, Yingze
description TOLLIP (Toll-interacting protein) is an intracellular adaptor protein with diverse actions throughout the body. In a context- and cell type-specific manner, TOLLIP can function as an inhibitor of inflammation and endoplasmic-reticulum stress, an activator of autophagy, or a critical regulator of intracellular vacuole trafficking. The distinct functions of this protein have been linked to innate immune responses and lung epithelial-cell apoptosis. genetic variants have been associated with a variety of chronic lung diseases, including idiopathic pulmonary fibrosis, asthma, and primary graft dysfunction after lung transplantation, and with infections, such as tuberculosis, pneumonia, and respiratory viruses. TOLLIP exists in a delicate homeostatic balance, with both positive and negative effects on the trajectory of pulmonary diseases. This translational review summarizes the genetic and molecular associations that link TOLLIP to the development and progression of noninfectious and infectious pulmonary diseases. We highlight current limitations of and models in assessing the role of TOLLIP in these conditions, and we describe future approaches that will enable a more nuanced exploration of the role of TOLLIP in pulmonary conditions. There has been a surge in recent research evaluating the role of this protein in human diseases, but critical mechanistic pathways require further exploration. By understanding its biologic functions in disease-specific contexts, we will be able to determine whether TOLLIP can be therapeutically modulated to treat pulmonary diseases.
doi_str_mv 10.1165/rcmb.2020-0470tr
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8086045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2464193344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-3786ba8748166fbbb095c7a58fc44943b15072f9c803a226407879587d36e90a3</originalsourceid><addsrcrecordid>eNpdkd1rFTEQxYMo9kPffZIFX3zZ6ySZbJIXobS2FgoWvT6HbG62Tc1ursmu0P_eLK1FhcAE5ncOM3MIeUNhQ2knPmQ39hsGDFpACXN-Rg6p4KJFrfTz-gfElgrUB-SolDsAyhSlL8kB54xzzeCQfNumGNvLafbZujlMN811TrMPU1Pf9RLHNNl835yF4m3xZdOc9GG3Yv19M9_65iLFXYjJ_ShVGCYX9tG_Ii8GG4t__ViPyffzT9vTz-3Vl4vL05Or1qGGueVSdb1VEhXtuqHve9DCSSvU4BA18p4KkGzQTgG3jHUIUkktlNzxzmuw_Jh8fPDdL_3od85Pc7bR7HMY68wm2WD-7Uzh1tykX0aB6gBFNXj_aJDTz8WX2YyhOB-jnXxaimHYIdWcI1b03X_oXVryVNczTCDUGyPKSsED5XIqJfvhaRgKZk3MrImZNTGzJrb9WiVv_17iSfAnIv4bRPySBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2540549447</pqid></control><display><type>article</type><title>Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle</title><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><creator>Li, Xiaoyun ; Goobie, Gillian C ; Gregory, Alyssa D ; Kass, Daniel J ; Zhang, Yingze</creator><creatorcontrib>Li, Xiaoyun ; Goobie, Gillian C ; Gregory, Alyssa D ; Kass, Daniel J ; Zhang, Yingze</creatorcontrib><description>TOLLIP (Toll-interacting protein) is an intracellular adaptor protein with diverse actions throughout the body. In a context- and cell type-specific manner, TOLLIP can function as an inhibitor of inflammation and endoplasmic-reticulum stress, an activator of autophagy, or a critical regulator of intracellular vacuole trafficking. The distinct functions of this protein have been linked to innate immune responses and lung epithelial-cell apoptosis. genetic variants have been associated with a variety of chronic lung diseases, including idiopathic pulmonary fibrosis, asthma, and primary graft dysfunction after lung transplantation, and with infections, such as tuberculosis, pneumonia, and respiratory viruses. TOLLIP exists in a delicate homeostatic balance, with both positive and negative effects on the trajectory of pulmonary diseases. This translational review summarizes the genetic and molecular associations that link TOLLIP to the development and progression of noninfectious and infectious pulmonary diseases. We highlight current limitations of and models in assessing the role of TOLLIP in these conditions, and we describe future approaches that will enable a more nuanced exploration of the role of TOLLIP in pulmonary conditions. There has been a surge in recent research evaluating the role of this protein in human diseases, but critical mechanistic pathways require further exploration. By understanding its biologic functions in disease-specific contexts, we will be able to determine whether TOLLIP can be therapeutically modulated to treat pulmonary diseases.</description><identifier>ISSN: 1044-1549</identifier><identifier>EISSN: 1535-4989</identifier><identifier>DOI: 10.1165/rcmb.2020-0470tr</identifier><identifier>PMID: 33233920</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Apoptosis ; Asthma ; Autophagy ; Cellular biology ; Fibrosis ; Genetic diversity ; Immune response ; Inflammation ; Innate immunity ; Intracellular ; Lung diseases ; Lung transplantation ; Phagocytosis ; Proteins ; Pulmonary fibrosis ; Translational Reviews ; Tuberculosis</subject><ispartof>American journal of respiratory cell and molecular biology, 2021-05, Vol.64 (5), p.536-546</ispartof><rights>Copyright American Thoracic Society May 2021</rights><rights>Copyright © 2021 by the American Thoracic Society 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-3786ba8748166fbbb095c7a58fc44943b15072f9c803a226407879587d36e90a3</citedby><cites>FETCH-LOGICAL-c490t-3786ba8748166fbbb095c7a58fc44943b15072f9c803a226407879587d36e90a3</cites><orcidid>0000-0001-6947-2901 ; 0000-0001-6597-7830 ; 0000-0001-7982-5635 ; 0000-0003-0000-9171 ; 0000-0002-0392-7202</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33233920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Xiaoyun</creatorcontrib><creatorcontrib>Goobie, Gillian C</creatorcontrib><creatorcontrib>Gregory, Alyssa D</creatorcontrib><creatorcontrib>Kass, Daniel J</creatorcontrib><creatorcontrib>Zhang, Yingze</creatorcontrib><title>Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle</title><title>American journal of respiratory cell and molecular biology</title><addtitle>Am J Respir Cell Mol Biol</addtitle><description>TOLLIP (Toll-interacting protein) is an intracellular adaptor protein with diverse actions throughout the body. In a context- and cell type-specific manner, TOLLIP can function as an inhibitor of inflammation and endoplasmic-reticulum stress, an activator of autophagy, or a critical regulator of intracellular vacuole trafficking. The distinct functions of this protein have been linked to innate immune responses and lung epithelial-cell apoptosis. genetic variants have been associated with a variety of chronic lung diseases, including idiopathic pulmonary fibrosis, asthma, and primary graft dysfunction after lung transplantation, and with infections, such as tuberculosis, pneumonia, and respiratory viruses. TOLLIP exists in a delicate homeostatic balance, with both positive and negative effects on the trajectory of pulmonary diseases. This translational review summarizes the genetic and molecular associations that link TOLLIP to the development and progression of noninfectious and infectious pulmonary diseases. We highlight current limitations of and models in assessing the role of TOLLIP in these conditions, and we describe future approaches that will enable a more nuanced exploration of the role of TOLLIP in pulmonary conditions. There has been a surge in recent research evaluating the role of this protein in human diseases, but critical mechanistic pathways require further exploration. By understanding its biologic functions in disease-specific contexts, we will be able to determine whether TOLLIP can be therapeutically modulated to treat pulmonary diseases.</description><subject>Apoptosis</subject><subject>Asthma</subject><subject>Autophagy</subject><subject>Cellular biology</subject><subject>Fibrosis</subject><subject>Genetic diversity</subject><subject>Immune response</subject><subject>Inflammation</subject><subject>Innate immunity</subject><subject>Intracellular</subject><subject>Lung diseases</subject><subject>Lung transplantation</subject><subject>Phagocytosis</subject><subject>Proteins</subject><subject>Pulmonary fibrosis</subject><subject>Translational Reviews</subject><subject>Tuberculosis</subject><issn>1044-1549</issn><issn>1535-4989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkd1rFTEQxYMo9kPffZIFX3zZ6ySZbJIXobS2FgoWvT6HbG62Tc1ursmu0P_eLK1FhcAE5ncOM3MIeUNhQ2knPmQ39hsGDFpACXN-Rg6p4KJFrfTz-gfElgrUB-SolDsAyhSlL8kB54xzzeCQfNumGNvLafbZujlMN811TrMPU1Pf9RLHNNl835yF4m3xZdOc9GG3Yv19M9_65iLFXYjJ_ShVGCYX9tG_Ii8GG4t__ViPyffzT9vTz-3Vl4vL05Or1qGGueVSdb1VEhXtuqHve9DCSSvU4BA18p4KkGzQTgG3jHUIUkktlNzxzmuw_Jh8fPDdL_3od85Pc7bR7HMY68wm2WD-7Uzh1tykX0aB6gBFNXj_aJDTz8WX2YyhOB-jnXxaimHYIdWcI1b03X_oXVryVNczTCDUGyPKSsED5XIqJfvhaRgKZk3MrImZNTGzJrb9WiVv_17iSfAnIv4bRPySBQ</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Li, Xiaoyun</creator><creator>Goobie, Gillian C</creator><creator>Gregory, Alyssa D</creator><creator>Kass, Daniel J</creator><creator>Zhang, Yingze</creator><general>American Thoracic Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6947-2901</orcidid><orcidid>https://orcid.org/0000-0001-6597-7830</orcidid><orcidid>https://orcid.org/0000-0001-7982-5635</orcidid><orcidid>https://orcid.org/0000-0003-0000-9171</orcidid><orcidid>https://orcid.org/0000-0002-0392-7202</orcidid></search><sort><creationdate>202105</creationdate><title>Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle</title><author>Li, Xiaoyun ; Goobie, Gillian C ; Gregory, Alyssa D ; Kass, Daniel J ; Zhang, Yingze</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-3786ba8748166fbbb095c7a58fc44943b15072f9c803a226407879587d36e90a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Apoptosis</topic><topic>Asthma</topic><topic>Autophagy</topic><topic>Cellular biology</topic><topic>Fibrosis</topic><topic>Genetic diversity</topic><topic>Immune response</topic><topic>Inflammation</topic><topic>Innate immunity</topic><topic>Intracellular</topic><topic>Lung diseases</topic><topic>Lung transplantation</topic><topic>Phagocytosis</topic><topic>Proteins</topic><topic>Pulmonary fibrosis</topic><topic>Translational Reviews</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Xiaoyun</creatorcontrib><creatorcontrib>Goobie, Gillian C</creatorcontrib><creatorcontrib>Gregory, Alyssa D</creatorcontrib><creatorcontrib>Kass, Daniel J</creatorcontrib><creatorcontrib>Zhang, Yingze</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory cell and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Xiaoyun</au><au>Goobie, Gillian C</au><au>Gregory, Alyssa D</au><au>Kass, Daniel J</au><au>Zhang, Yingze</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle</atitle><jtitle>American journal of respiratory cell and molecular biology</jtitle><addtitle>Am J Respir Cell Mol Biol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>64</volume><issue>5</issue><spage>536</spage><epage>546</epage><pages>536-546</pages><issn>1044-1549</issn><eissn>1535-4989</eissn><abstract>TOLLIP (Toll-interacting protein) is an intracellular adaptor protein with diverse actions throughout the body. In a context- and cell type-specific manner, TOLLIP can function as an inhibitor of inflammation and endoplasmic-reticulum stress, an activator of autophagy, or a critical regulator of intracellular vacuole trafficking. The distinct functions of this protein have been linked to innate immune responses and lung epithelial-cell apoptosis. genetic variants have been associated with a variety of chronic lung diseases, including idiopathic pulmonary fibrosis, asthma, and primary graft dysfunction after lung transplantation, and with infections, such as tuberculosis, pneumonia, and respiratory viruses. TOLLIP exists in a delicate homeostatic balance, with both positive and negative effects on the trajectory of pulmonary diseases. This translational review summarizes the genetic and molecular associations that link TOLLIP to the development and progression of noninfectious and infectious pulmonary diseases. We highlight current limitations of and models in assessing the role of TOLLIP in these conditions, and we describe future approaches that will enable a more nuanced exploration of the role of TOLLIP in pulmonary conditions. There has been a surge in recent research evaluating the role of this protein in human diseases, but critical mechanistic pathways require further exploration. By understanding its biologic functions in disease-specific contexts, we will be able to determine whether TOLLIP can be therapeutically modulated to treat pulmonary diseases.</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>33233920</pmid><doi>10.1165/rcmb.2020-0470tr</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6947-2901</orcidid><orcidid>https://orcid.org/0000-0001-6597-7830</orcidid><orcidid>https://orcid.org/0000-0001-7982-5635</orcidid><orcidid>https://orcid.org/0000-0003-0000-9171</orcidid><orcidid>https://orcid.org/0000-0002-0392-7202</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1044-1549
ispartof American journal of respiratory cell and molecular biology, 2021-05, Vol.64 (5), p.536-546
issn 1044-1549
1535-4989
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8086045
source Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection
subjects Apoptosis
Asthma
Autophagy
Cellular biology
Fibrosis
Genetic diversity
Immune response
Inflammation
Innate immunity
Intracellular
Lung diseases
Lung transplantation
Phagocytosis
Proteins
Pulmonary fibrosis
Translational Reviews
Tuberculosis
title Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A47%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toll-Interacting%20Protein%20in%20Pulmonary%20Diseases.%20Abiding%20by%20the%20Goldilocks%20Principle&rft.jtitle=American%20journal%20of%20respiratory%20cell%20and%20molecular%20biology&rft.au=Li,%20Xiaoyun&rft.date=2021-05&rft.volume=64&rft.issue=5&rft.spage=536&rft.epage=546&rft.pages=536-546&rft.issn=1044-1549&rft.eissn=1535-4989&rft_id=info:doi/10.1165/rcmb.2020-0470tr&rft_dat=%3Cproquest_pubme%3E2464193344%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2540549447&rft_id=info:pmid/33233920&rfr_iscdi=true